As previous studies investigating BCL9 and BCL9l (BCL9/9l) were performed in colitis-associated cancer models, we wished to investigate the effect in models of cancer directly driven by activation of Wnt signalling either by Apc gene deletion or β-catenin stabilisation. This evidence concerns the gene BCL9L and cancer.